首頁 › 過重 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 過重 臨床試驗
16 項針對 過重 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
招募中2 期
- University of Alabama - Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
招募中3 期
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
招募中3 期
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
招募中
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
招募中
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
招募中
- The Worship Center Cristian Church, Birmingham
其他城市的 過重 試驗
- San Antonio, TX34 項研究
- Houston, TX33 項研究
- Chicago, IL28 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Atlanta, GA20 項研究
- Dallas, TX20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Austin, TX18 項研究
Birmingham 的其他研究
- 癌症（所有類型）30 項研究
- 乳癌24 項研究
- 肥胖症23 項研究
- 卵巢癌23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 子宮內膜癌16 項研究
- 第二型糖尿病16 項研究
- 囊腫性纖維化16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。